Hi Sammy
Yes Duvystat phase 3 trial concludes end 2026
Not really a competitor to Avircusen..
Cap1102 more to do with DMD heart treatment
They are trying to going see the FDA Re Hope 2 results by years end
Hope 3 mid results in the first 1/4 2025
Lets hope the CR is going to institutional investors
and not just retail
We are on the same team Sammy
Thanks for your input today
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $8.495K | 918.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1277347 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1853198 | 6 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |